Maaz Mohiuddin

105 posts
Providing relief to patients who have struggled with allergic disease is what drives me to be at the forefront of our field. I trained in an environment where we saw the most challenging cases of atopic dermatitis (eczema), asthma, food allergies, and other allergic conditions in patients from all around the world. I was mentored by world renowned allergists, at National Jewish Health, who have written many of the guidelines we follow today. And despite being surrounded by the most advanced diagnostics and minds, I learned that spending time with the patient educating them about their disease and the treatments, ensuring proper technique, is what most often leads to drastic improvements in their quality of life. My goal is that every patient leaves our office feeling empowered and involved in the decision making process of their health with no questions unanswered. I especially look forward to treating the most challenging cases in patients who have suffered too long with no relief despite multiple doctor visits.

FDA Clears First Epinephrine Autoinjector for Infants

The US Food and Drug Administration (FDA) has approved the first and only epinephrine autoinjector (EAI) specifically designed for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and children weighing 16.5 to 33 pounds (7.5 to 15 kg), according to a company statement. Auvi-Q is a compact epinephrine […]